• Cefepime vs. Piperacillin-Tazobactam for Infection? The ACORN Trial

  • Jun 7 2024
  • Length: 22 mins
  • Podcast

Cefepime vs. Piperacillin-Tazobactam for Infection? The ACORN Trial

Listen for free

View show details

  • Summary

  • Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical. Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism. The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam. In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin. In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Cefepime vs. Piperacillin-Tazobactam for Infection? The ACORN Trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available